肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

观察对象:滤泡性淋巴瘤后的免疫微环境

Entourage: the immune microenvironment following follicular lymphoma

原文发布日期:2012-01-20

DOI: 10.1038/bcj.2011.53

类型: Original Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

观察对象:滤泡性淋巴瘤后的免疫微环境

Entourage: the immune microenvironment following follicular lymphoma

原文发布日期:2012-01-20

DOI: 10.1038/bcj.2011.53

类型: Original Article

开放获取: 是

 

英文摘要:

In follicular lymphoma, nonmalignant immune cells are important. Follicular lymphoma depends on CD4+ cells, but CD8+ cells counteract it. We hypothesized that the presence of follicular lymphoma is associated with higher CD4+ than CD8+ cell numbers in the tumor microenvironment but not in the immune system. Using flow cytometry, pre-treatment and follow-up CD4/CD8 ratios were estimated in the bone marrow, blood and lymph nodes of untreated follicular lymphoma patients in two independent data sets (N1=121; N2=166). The ratios were analyzed for their relation with bone marrow lymphoma involvement. Bone marrows were also investigated with immunohistochemistry. In either data set, the bone marrow CD4/CD8 ratios were higher in bone marrows involved with lymphoma (P=0.043 and 0.0002, respectively). The mean CD4/CD8 ratio was 1.0 in uninvolved and 1.4 in involved bone marrows. Also higher in involved bone marrows were CD4/CD56 and CD3CD25/CD3 ratios. No blood or lymph node ratios differed between bone marrow-negative and -positive patients. Sequential samples showed increased bone marrow CD4/CD8 ratios in all cases of progression to bone marrow involvement. Immunohistochemistry showed CD4+, CD57+, programmed death-1+, forkhead box protein 3+ and CD21+ cells accumulated inside the lymphoma infiltrates, whereas CD8+, CD56+ and CD68+ cells were outside the infiltrates. This study provides evidence in vivo that the microenvironment changes upon follicular lymphoma involvement.

 

摘要翻译: 

在滤泡性淋巴瘤中,非恶性免疫细胞具有重要作用。滤泡性淋巴瘤依赖CD4+细胞,但CD8+细胞对其有抑制作用。我们假设滤泡性淋巴瘤的存在与肿瘤微环境中CD4+细胞数量高于CD8+细胞相关,但在免疫系统中并非如此。利用流式细胞术,在两个独立数据集(N1=121;N2=166)中,对未治疗的滤泡性淋巴瘤患者的骨髓、血液和淋巴结中的CD4/CD8比值进行了治疗前和随访期的评估。分析了这些比值与骨髓淋巴瘤受累的关系。骨髓还通过免疫组织化学进行了研究。在两个数据集中,受累骨髓的CD4/CD8比值均较高(P值分别为0.043和0.0002)。未受累骨髓的平均CD4/CD8比值为1.0,而受累骨髓为1.4。受累骨髓中CD4/CD56和CD3CD25/CD3比值也较高。骨髓阴性患者与阳性患者之间的血液或淋巴结比值无差异。连续样本显示,在所有进展为骨髓受累的病例中,骨髓CD4/CD8比值均增加。免疫组织化学显示,CD4+、CD57+、程序性死亡-1+、叉头框蛋白3+和CD21+细胞聚集在淋巴瘤浸润灶内,而CD8+、CD56+和CD68+细胞位于浸润灶外。本研究在体内提供了证据,表明滤泡性淋巴瘤受累时微环境会发生改变。

 

原文链接:

Entourage: the immune microenvironment following follicular lymphoma

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……